Feasibility of photodynamic therapy for secondary hyperparathyroidism in chronic renal failure rats-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Feasibility of photodynamic therapy for secondary hyperparathyroidism in chronic renal failure rats

Published:2016-10-18 Issue:4 Volume:21 Page:563-572
ISSN:1342-1751
Container-title:Clinical and Experimental Nephrology
language:en
Short-container-title:Clin Exp Nephrol

Author:

Miyakogawa Takayo,Kanai Genta,Tatsumi Ryoko,Takahashi Hiroo,Sawada Kaichiro,Kakuta Takatoshi,Fukagawa Masafumi

Funder

Torii Pharmaceutical Co., Ltd.

Kyowa Hakko Kirin Co., Ltd.

Publisher

Springer Science and Business Media LLC

Subject

Physiology (medical),Nephrology,Physiology

Link

http://link.springer.com/article/10.1007/s10157-016-1335-z/fulltext.html

Reference25 articles.

1. Wilson BC, Patterson MS. The physics, biophysics and technology of photodynamic therapy. Phys Med Biol. 2008;53:R61–109.

2. Agostinis P, Berg K, Cengel KA, et al. Photodynamic therapy of cancer: an update. CA Cancer J Clin. 2011;61:250–81.

3. Huang Z, Xu H, Meyer AD, Musani AI, Wang L, Tagg R, Barqawi AB, Chen YK. Photodynamic therapy for solid tumors—potential and technical challenges. Technol Cancer Res Treat. 2008;7:309–20.

4. Wachowska M, Muchowicz A, Firczuk M, Gabrysiak M, Winiarska M, Wanczyk M, Bojarczuk K, Golab J. Aminolevulinic acid (ALA) as a prodrug in photodynamic therapy of cancer. Molecules. 2011;16:4140–64.

5. Komaba H, Kakuta T, Fukagawa M. Diseases of the parathyroid gland in chronic kidney disease. Clin Exp Nephrol. 2011;15:797–809.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Secondary hyperparathyroidism in chronic kidney disease: pathophysiology, current treatments and investigational drugs;Expert Opinion on Investigational Drugs;2024-06-19

2. RNA-Seq-based transcriptomics analysis during the photodynamic therapy of primary cells in secondary hyperparathyroidism;Photochemical & Photobiological Sciences;2023-02-07

3. Progress in the Treatment of Secondary Hy-perparathyroidism;Advances in Clinical Medicine;2023

4. Advances in the treatment of secondary and tertiary hyperparathyroidism;Frontiers in Endocrinology;2022-12-06

5. Inhibition of autophagy with Chloroquine enhanced apoptosis induced by 5-aminolevulinic acid-photodynamic therapy in secondary hyperparathyroidism primary cells and organoids;Biomedicine & Pharmacotherapy;2021-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3